The long-term goals of the proposed research are to elucidate the mechanisms that regulate apoptosis of neurons in the developing mammalian brain. Growing evidence suggests that components of the cell cycle are reactivated in dying neurons in the brain. However, the role and mechanisms by which the cell cycle machinery control apoptosis of neurons remain largely to be elucidated. We have found that the mitotic kinase Cdc2 induces apoptosis in primary rat cerebellar granule neurons. These findings raise two major questions: how does Cdc2 trigger apoptosis of postmitotic neurons, and what is the role of Cdc2 function in neuronal apoptosis in the intact developing cerebellar cortex? To address these questions we propose the following specific aims: (1) Elucidate the mechanisms by which Cdc2 induces neuronal apoptosis. Our preliminary studies suggest the hypothesis that Cdc2 triggers apoptosis by phosphorylating protein substrates of the major pro-survival kinase Akt with the net effect of opposing Akt-promotion of neuronal survival. We will take a multi-pronged approach to identify novel substrates of Cdc2 that contribute to neuronal apoptosis. (2) Determine Cdc2 function in the intact cerebellar cortex. We will characterize the expression and activity of Cdc2 in granule neurons in the rat cerebellar cortex in both rat cerebellar slices and in vivo, and we will determine the effect of inhibition of Cdc2 on neuronal apoptosis in the cerebellar cortex. Together, the proposed research should provide fundamental and novel insights into the role and mechanisms of cell cycle reactivation in apoptosis of postmitotic neurons. Since cell cycle reactivation is thought to play an important role in neurodegenerative diseases, our studies should also lead to novel insights into the pathogenesis of these devastating diseases of brain. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
1R01NS047188-01A2
Application #
7209653
Study Section
Special Emphasis Panel (ZRG1-NOMD-A (01))
Program Officer
Tagle, Danilo A
Project Start
2007-02-01
Project End
2011-01-31
Budget Start
2007-02-01
Budget End
2008-01-31
Support Year
1
Fiscal Year
2007
Total Cost
$333,129
Indirect Cost
Name
Harvard University
Department
Pathology
Type
Schools of Medicine
DUNS #
047006379
City
Boston
State
MA
Country
United States
Zip Code
02115
Bilimoria, Parizad M; Bonni, Azad (2013) Molecular control of axon branching. Neuroscientist 19:16-24
Singh, Sasha A; Winter, Dominic; Bilimoria, Parizad M et al. (2012) FLEXIQinase, a mass spectrometry-based assay, to unveil multikinase mechanisms. Nat Methods 9:504-8
Huynh, Mai Anh; Ikeuchi, Yoshiho; Netherton, Stuart et al. (2011) An isoform-specific SnoN1-FOXO1 repressor complex controls neuronal morphogenesis and positioning in the mammalian brain. Neuron 69:930-44
Bilimoria, Parizad M; de la Torre-Ubieta, Luis; Ikeuchi, Yoshiho et al. (2010) A JIP3-regulated GSK3ýý/DCX signaling pathway restricts axon branching. J Neurosci 30:16766-76
Lehtinen, Maria K; Tegelberg, Saara; Schipper, Hyman et al. (2009) Cystatin B deficiency sensitizes neurons to oxidative stress in progressive myoclonus epilepsy, EPM1. J Neurosci 29:5910-5
Yuan, Zengqiang; Lehtinen, Maria K; Merlo, Paola et al. (2009) Regulation of neuronal cell death by MST1-FOXO1 signaling. J Biol Chem 284:11285-92
de la Iglesia, Núria; Puram, Sidharth V; Bonni, Azad (2009) STAT3 regulation of glioblastoma pathogenesis. Curr Mol Med 9:580-90
Kim, Albert H; Bonni, Azad (2008) Cdk1-FOXO1: a mitotic signal takes center stage in post-mitotic neurons. Cell Cycle 7:3819-22
Oberdoerffer, Philipp; Michan, Shaday; McVay, Michael et al. (2008) SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell 135:907-18
de la Iglesia, Nuria; Konopka, Genevieve; Lim, Kah-Leong et al. (2008) Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness. J Neurosci 28:5870-8

Showing the most recent 10 out of 14 publications